nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—psoriatic arthritis—osteoarthritis	0.301	0.39	CtDrD
Betamethasone—ankylosing spondylitis—osteoarthritis	0.248	0.321	CtDrD
Betamethasone—rheumatoid arthritis—osteoarthritis	0.223	0.289	CtDrD
Betamethasone—PTGS2—osteoarthritis	0.222	1	CbGaD
Betamethasone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.000402	0.0663	CbGpPWpGaD
Betamethasone—CYP19A1—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.000394	0.065	CbGpPWpGaD
Betamethasone—PTGS2—Eicosanoid Synthesis—PTGES—osteoarthritis	0.000261	0.0431	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—FRZB—osteoarthritis	0.0002	0.0329	CbGpPWpGaD
Betamethasone—NR3C2—ACE Inhibitor Pathway—TGFB1—osteoarthritis	0.000183	0.0302	CbGpPWpGaD
Betamethasone—PGR—Ovarian Infertility Genes—SMAD3—osteoarthritis	0.000159	0.0262	CbGpPWpGaD
Betamethasone—NR3C2—Nuclear Receptor transcription pathway—ESR1—osteoarthritis	0.000147	0.0242	CbGpPWpGaD
Betamethasone—PTGS2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000145	0.0239	CbGpPWpGaD
Betamethasone—PGR—Cellular roles of Anthrax toxin—IL1B—osteoarthritis	0.000117	0.0192	CbGpPWpGaD
Betamethasone—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.000115	0.019	CbGpPWpGaD
Betamethasone—PGR—Nuclear Receptors—ESR1—osteoarthritis	0.000113	0.0186	CbGpPWpGaD
Betamethasone—PGR—Nuclear signaling by ERBB4—ESR1—osteoarthritis	0.000111	0.0182	CbGpPWpGaD
Betamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	0.000107	0.0176	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoarthritis	0.000106	0.0174	CbGpPWpGaD
Betamethasone—CYP19A1—Ovarian Infertility Genes—SMAD3—osteoarthritis	0.000104	0.0172	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—CRP—osteoarthritis	9.22e-05	0.0152	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—SOX9—osteoarthritis	8.97e-05	0.0148	CbGpPWpGaD
Betamethasone—PGR—Nuclear Receptor transcription pathway—ESR1—osteoarthritis	8.93e-05	0.0147	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	8.51e-05	0.014	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—FN1—osteoarthritis	8.51e-05	0.014	CbGpPWpGaD
Betamethasone—PGR—Cellular roles of Anthrax toxin—TNF—osteoarthritis	8.47e-05	0.014	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—ESR1—osteoarthritis	7.44e-05	0.0123	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoarthritis	7.27e-05	0.012	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TIMP1—osteoarthritis	6.97e-05	0.0115	CbGpPWpGaD
Betamethasone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	6.57e-05	0.0108	CbGpPWpGaD
Betamethasone—NR3C1—Nuclear Receptors—ESR1—osteoarthritis	6.53e-05	0.0108	CbGpPWpGaD
Betamethasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoarthritis	6.53e-05	0.0108	CbGpPWpGaD
Betamethasone—Fluoxymesterone—ESR1—osteoarthritis	6.14e-05	0.588	CrCbGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—CXCL8—osteoarthritis	6e-05	0.00988	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—GSTO1—osteoarthritis	5.7e-05	0.0094	CbGpPWpGaD
Betamethasone—CYP19A1—Metapathway biotransformation—GSTO1—osteoarthritis	5.62e-05	0.00927	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	5.28e-05	0.00871	CbGpPWpGaD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoarthritis	5.16e-05	0.0085	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—SMAD3—osteoarthritis	5.02e-05	0.00828	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoarthritis	4.9e-05	0.00807	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—BMP2—osteoarthritis	4.77e-05	0.00786	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—COL2A1—osteoarthritis	4.75e-05	0.00783	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—FMOD—osteoarthritis	4.65e-05	0.00766	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—osteoarthritis	4.37e-05	0.0072	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MMP1—osteoarthritis	4.33e-05	0.00714	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	4.25e-05	0.007	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—TNF—osteoarthritis	4.17e-05	0.00688	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—ESR1—osteoarthritis	4e-05	0.0066	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoarthritis	3.95e-05	0.00651	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—osteoarthritis	3.82e-05	0.00629	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGES—osteoarthritis	3.79e-05	0.00625	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	3.75e-05	0.00618	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—ESR1—osteoarthritis	3.73e-05	0.00614	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoarthritis	3.56e-05	0.00587	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	3.37e-05	0.00555	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	3.11e-05	0.00512	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—SMAD3—osteoarthritis	3.1e-05	0.00511	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—SMAD3—osteoarthritis	2.99e-05	0.00493	CbGpPWpGaD
Betamethasone—Triamcinolone—PTGS2—osteoarthritis	2.92e-05	0.279	CrCbGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CXCL8—osteoarthritis	2.79e-05	0.00459	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	2.77e-05	0.00456	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	2.76e-05	0.00455	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	2.71e-05	0.00446	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL1A—osteoarthritis	2.7e-05	0.00445	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GSTO1—osteoarthritis	2.67e-05	0.0044	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	2.66e-05	0.00438	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—BGN—osteoarthritis	2.59e-05	0.00426	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	2.56e-05	0.00422	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—LEP—osteoarthritis	2.56e-05	0.00421	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—ESR1—osteoarthritis	2.53e-05	0.00417	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MMP9—osteoarthritis	2.52e-05	0.00415	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL1A—osteoarthritis	2.5e-05	0.00412	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—osteoarthritis	2.46e-05	0.00405	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	2.46e-05	0.00405	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	2.36e-05	0.00389	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—TGFB1—osteoarthritis	2.13e-05	0.0035	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IGF1—osteoarthritis	2.11e-05	0.00348	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	2.09e-05	0.00345	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TGFB1—osteoarthritis	2.08e-05	0.00342	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	2.08e-05	0.00342	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	2.06e-05	0.00339	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MCF2L—osteoarthritis	1.93e-05	0.00318	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IHH—osteoarthritis	1.93e-05	0.00318	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	1.92e-05	0.00317	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—SMAD3—osteoarthritis	1.89e-05	0.00311	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—FMOD—osteoarthritis	1.7e-05	0.0028	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	1.69e-05	0.00278	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.67e-05	0.00275	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	1.66e-05	0.00274	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	1.64e-05	0.0027	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL6—osteoarthritis	1.57e-05	0.00258	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—ESR1—osteoarthritis	1.54e-05	0.00254	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SMAD3—osteoarthritis	1.49e-05	0.00246	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	1.47e-05	0.00242	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—IL6—osteoarthritis	1.46e-05	0.0024	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—COL9A2—osteoarthritis	1.42e-05	0.00233	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	1.41e-05	0.00232	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	1.39e-05	0.00229	CbGpPWpGaD
Betamethasone—Dexamethasone—PTGS2—osteoarthritis	1.39e-05	0.133	CrCbGaD
Betamethasone—CYP19A1—Metabolism—PTGES—osteoarthritis	1.38e-05	0.00228	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoarthritis	1.38e-05	0.00227	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—COL9A1—osteoarthritis	1.38e-05	0.00227	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	1.36e-05	0.00224	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	1.36e-05	0.00224	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FMOD—osteoarthritis	1.35e-05	0.00223	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	1.33e-05	0.0022	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL1B—osteoarthritis	1.3e-05	0.00215	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TGFB1—osteoarthritis	1.27e-05	0.00209	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	1.26e-05	0.00207	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	1.22e-05	0.00202	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ESR1—osteoarthritis	1.22e-05	0.00201	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IHH—osteoarthritis	1.21e-05	0.00199	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TNF—osteoarthritis	1.18e-05	0.00195	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	1.18e-05	0.00194	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—FMOD—osteoarthritis	1.13e-05	0.00187	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—SMAD3—osteoarthritis	1.09e-05	0.0018	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	1.04e-05	0.00171	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoarthritis	1.02e-05	0.00168	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	1.01e-05	0.00167	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	9.88e-06	0.00163	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTO1—osteoarthritis	9.75e-06	0.00161	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	9.68e-06	0.0016	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	9.64e-06	0.00159	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IL6—osteoarthritis	9.54e-06	0.00157	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—osteoarthritis	9.46e-06	0.00156	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—BGN—osteoarthritis	9.45e-06	0.00156	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BMP2—osteoarthritis	9.43e-06	0.00155	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTGES—osteoarthritis	9.25e-06	0.00152	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SMAD3—osteoarthritis	9.1e-06	0.0015	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFBI—osteoarthritis	9e-06	0.00148	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—ESR1—osteoarthritis	8.91e-06	0.00147	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	8.34e-06	0.00137	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoarthritis	8.25e-06	0.00136	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—FMOD—osteoarthritis	8.04e-06	0.00133	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	7.81e-06	0.00129	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GSTO1—osteoarthritis	7.78e-06	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BGN—osteoarthritis	7.54e-06	0.00124	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—osteoarthritis	7.44e-06	0.00123	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ESR1—osteoarthritis	7.42e-06	0.00122	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	7.05e-06	0.00116	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	6.92e-06	0.00114	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	6.59e-06	0.00109	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGES—osteoarthritis	6.56e-06	0.00108	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP3—osteoarthritis	6.53e-06	0.00108	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTO1—osteoarthritis	6.52e-06	0.00107	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—BGN—osteoarthritis	6.31e-06	0.00104	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	6.1e-06	0.001	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SMAD3—osteoarthritis	5.91e-06	0.000975	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SMAD3—osteoarthritis	5.26e-06	0.000866	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LEP—osteoarthritis	5.06e-06	0.000833	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	5e-06	0.000824	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—FMOD—osteoarthritis	4.96e-06	0.000817	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ESR1—osteoarthritis	4.83e-06	0.000795	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FN1—osteoarthritis	4.77e-06	0.000786	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	4.67e-06	0.000769	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTO1—osteoarthritis	4.62e-06	0.000761	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BGN—osteoarthritis	4.47e-06	0.000737	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR1—osteoarthritis	4.29e-06	0.000707	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—osteoarthritis	4.18e-06	0.000688	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGES—osteoarthritis	4.04e-06	0.000666	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SMAD3—osteoarthritis	3.7e-06	0.00061	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—osteoarthritis	3.36e-06	0.000554	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—osteoarthritis	3.04e-06	0.000501	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTO1—osteoarthritis	2.85e-06	0.000469	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BGN—osteoarthritis	2.76e-06	0.000454	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—osteoarthritis	2.72e-06	0.000448	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—osteoarthritis	2.5e-06	0.000413	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—osteoarthritis	1.89e-06	0.000311	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—osteoarthritis	1.57e-06	0.000258	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—osteoarthritis	1.29e-06	0.000212	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—osteoarthritis	1.18e-06	0.000195	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—osteoarthritis	7.93e-07	0.000131	CbGpPWpGaD
